Community pharmacists in Saudi Arabia frequently recommend OTC melatonin for insomnia but provide brief consultations, incomplete history taking, limited safety counseling, and rare non-pharmacological advice.
In a cross-sectional study using 251 simulated patient visits across Saudi Arabia, community pharmacists recommended OTC melatonin in 64.5% of cases, but consultations lasted only a median of 1.5 minutes. History taking was incomplete (e.g., sleep patterns inquired in 55.4%, triggers in 51%), safety information was provided in only 4.9% of visits, and non-pharmacological advice was given in just 9.6%.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Community pharmacists in Saudi Arabia frequently recommend OTC melatonin for insomnia but provide brief consultations, incomplete history taking, limited safety counseling, and rare non-pharmacological advice. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Community pharmacists in Saudi Arabia frequently recommend OTC melatonin for insomnia but provide brief consultations, incomplete history taking, limited safety counseling, and rare non-pharmacological advice.
This conclusion is most relevant to: Community pharmacists in urban, suburban, and rural areas of Saudi Arabia (251 simulated visits).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Evaluating community pharmacists' practices in managing insomnia in Saudi Arabia: a cross-sectional study using simulated patient visits. (Frontiers in public health, 2026) —
How It Works
The proposed biological pathway:
- ▸Pharmacist encounters simulated patient with insomnia complaint
- ▸Pharmacist conducts brief consultation (median 1.5 min)
- ▸Pharmacist recommends OTC melatonin (64.5%)
- ▸Limited history taking, safety counseling, and non-pharmacological advice observed
Who Might Benefit
Evidence fit by population:
- ▸Community pharmacists in urban, suburban, and rural areas of Saudi Arabia (251 simulated visits)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Cross-sectional design limits causal inference
- ▸Simulated patient methodology may not fully capture real-world pharmacist behavior
- ▸Regional sample imbalance (rural only 7.2% of visits)
Frequently Asked Questions
What percentage of pharmacists recommended melatonin for insomnia?▼
64.5% of pharmacists recommended OTC melatonin.
How long did the average consultation last?▼
The median consultation duration was 1.5 minutes (interquartile range 1-2 minutes).
Did pharmacists provide safety information about insomnia treatments?▼
Safety information was provided in only 4.9% of visits.
What non-pharmacological advice was given?▼
Non-pharmacological advice was given in only 9.6% of visits, though specific types were not detailed in the abstract.
References
- 1.Algarni M, Alghamdi S, Barakat BM, Alshammari TM, Alzahrani A, Alzahrani A, Sumayli H, Al-Qahtani SA, Mantargi MJS. “Evaluating community pharmacists' practices in managing insomnia in Saudi Arabia: a cross-sectional study using simulated patient visits..” Frontiers in public health, 2026. PMID: 42395279 DOI: 10.3389/fpubh.2026.1792148